M. Arnone

Selective inhibition of sucrose and ethanol intake by SR 141716, an antagonist of central cannabinoid (CB1) receptors

M. Arnone, Jeanne Maruani, Frédérique Chaperon et al. · Psychopharmacology · 1997 · 594 citations

Cannabis Use, Psychoactive Drug, Health Sciences +12

CB1 cannabinoid receptor knockout in mice leads to leanness, resistance to diet-induced obesity and enhanced leptin sensitivity

Christine Ravinet Trillou, Claire Delgorge, Christel Menet et al. · International Journal of Obesity · 2004 · 585 citations

Obesity, Molecular Pharmacology, Metabolic Syndrome +15

Anti-obesity effect of SR141716, a CB1 receptor antagonist, in diet-induced obese mice

Christine Ravinet Trillou, M. Arnone, Claire Delgorge et al. · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · 2003 · 564 citations

The CB1 receptor antagonist rimonabant reverses the diet‐induced obesity phenotype through the regulation of lipolysis and energy balance

Omar Jbilo, Christine Ravinet‐Trillou, M. Arnone et al. · The FASEB Journal · 2005 · 345 citations

Energy Balance, Metabolic Remodeling, Insulin Signaling +22

Rimonabant reduces obesity-associated hepatic steatosis and features of metabolic syndrome in obese Zucker fa/fa rats

Magali Gary‐Bobo, Ghizlane Elachouri, Jean François Gallas et al. · Hepatology · 2007 · 302 citations · Full text

Metabolic Disorder, Pathology, Fatty Liver Disease +17